IMV Inc.

OTCPK:IMVI.F Stock Report

Market Cap: US$14.0

IMV Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Andrew Hall

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.9yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure3.7yrs

Recent management updates

Recent updates

Seeking Alpha Sep 15

IMV to cut ~33% workforce amid reorganization

IMV (NASDAQ:IMV) said it was undertaking a reorganization and reducing its workforce by nearly one third. The company will focus on its DPX platform and advance its lead DPX asset Maveropepimut-S (MVP-S), IMV said in a Sept. 15 press release. IMV intends to focus its resources on ongoing MVP-S clinical programs in immuno-oncology (IO), notably phase 2b trials VITALIZE in relapsed/ refractory Diffuse Large B Cell Lymphoma (DLBCL) and AVALON for advanced metastatic ovarian cancer. In addition, the Canadian company said that Saman Maleki was appointed to the board replacing Brittany Davison who will be promoted to chief accounting officer from her current role as senior vice president, Finance. Maleki is an Assistant Professor of Oncology, Pathology & Laboratory Medicine, and Medical Biophysics at Western University and is an expert in the field of immuno-oncology, according to IMV. IMV +4.05% to $0.77 premarket Sept. 15
Seeking Alpha Jul 08

IMV receives Nasdaq non-compliance letter

IMV (NASDAQ:IMV) received a letter from Nasdaq for not meeting the minimum bid price of $1.00 per share required for continued listing. Company may be eligible for an additional 180 calendar days to regain compliance.

CEO Compensation Analysis

How has Andrew Hall's remuneration changed compared to IMV's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2022US$1mUS$480k

-US$38m

Sep 30 2022n/an/a

-US$41m

Jun 30 2022n/an/a

-US$43m

Mar 31 2022n/an/a

-US$40m

Dec 31 2021US$884kUS$381k

-US$37m

Sep 30 2021n/an/a

-US$32m

Jun 30 2021n/an/a

-US$28m

Mar 31 2021n/an/a

-US$26m

Dec 31 2020US$511kUS$40k

-US$26m

Compensation vs Market: Insufficient data to establish whether Andrew's total compensation is reasonable compared to companies of similar size in the US market.

Compensation vs Earnings: Insufficient data to compare Andrew's compensation with company performance.


CEO

Andrew Hall

4.9yrs
Tenure
US$1,020,100
Compensation

Mr. Andrew Hall, B. Med. Sci., M.Sc. serves as the Chief Executive Officer, Secretary & Board Member of Consano Bio, Inc. and serves as its Treasurer. He was Chief Executive Officer of IMV Inc. since Decem...


Board Members

NamePositionTenureCompensationOwnership
Andrew Hall
CEO & Director4.5yrsUS$1.02mno data
Brittany Davison
Corporate Secretary & Director3.3yrsUS$388.50kno data
Shermaine Tilley
Independent Director2.1yrsno datano data
Nina Bhardwaj
Member of Scientific & Clinical Advisory Committeeno datano datano data
Jose Iglesias
Member of Scientific & Clinical Advisory Committeeno datano datano data
Shabnam Kazmi
Independent Director3.5yrsno datano data
Michael Kalos
Independent Director and Member of Scientific & Clinical Advisory Committee5.2yrsUS$108.25kno data
Saman Maleki
Independent Director3.8yrsUS$135.01kno data
3.7yrs
Average Tenure
69yo
Average Age

Experienced Board: IMVI.F's board of directors are considered experienced (3.7 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/09 04:44
End of Day Share Price 2026/06/02 00:00
Earnings2022/12/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

IMV Inc. is covered by 8 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sarah ChiassonBeacon Securities Limited
Mayank MamtaniB. Riley Securities, Inc.
Thomas ShraderBTIG